Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2007 041 775.9 |
| 96 | EP file number | EAKZ | 11 19 3793.4 |
| 97 | EP publication number | EPN | 2441472 |
| 54 | Designation/title | TI | Tumortherapie mit einem Anti-VEGF-Antikörper |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/395 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C07K 16/00 (2006.01) |
| 22 | DE application date | DAT | Aug 17, 2007 |
| 96 | EP application date | EAT | Aug 17, 2007 |
| 43 | Date of first publication | OT | Apr 18, 2012 |
| Date of publication of grant | PET | Jun 10, 2015 |
| 71/73 | Applicant/owner | INH | F. Hoffmann-La Roche AG, Basel, CH |
| 72 | Inventor | IN | Friess, Thomas, 86911 Diessen-Dettenhofen, DE; Hasmann, Max, 81377 Muenchen, DE; Scheuer, Werner, 82377 Penzberg, DE |
| 74 | Representative | VTR | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
| Address for service | | VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, 81675 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| EP
06017330
Aug 21, 2006
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002441472
Searchable text:
EP000002441472
Original document:
EP000002441472B1
Searchable text:
EP000002441472B1 |
| 43 | Date of first publication | EVT | Apr 18, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Jun 1, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025
(Show all update days)(Hide all update days)- Jan 5, 2025
- Address for service: changed
- Jun 1, 2012
- Date of the first transfer into DPMAregister
|
